Canadian International Pharma Corp. (TSXV:CIP.H) announced a non-brokered private placement of up to 8,888,888 units at a price of CAD 0.1125 per unit for gross proceeds of up to CAD 1,000,000 on August 21, 2020. Each unit will consist of one post-consolidation share and one share purchase warrant. Each warrant will entitle the holder to purchase one post consolidation common share at an exercise price of CAD 0.15 per share for a period of 12 months following the closing date. All securities issued in the transaction will be subject to a statutory hold period expiring four months and one day. The transaction is subject to number of conditions, including, without limitation, receipt of all regulatory approvals, including approval of the TSX Venture Exchange.